查詢結果分析
相關文獻
- Low Use of Statins in Patients with Acute Myocardial Infarction: A Single Center Experience
- Statin Therapy is Associated with Improved Clinical Outcomes in Patients Undergoing Emergency Percutaneous Coronary Intervention
- 急性心肌梗塞住院病人的不確定感與因應行為之探討
- Myocardial Contrast Echocardiography and Dobutamine Echocardiography in Predicting Viable Myocardium
- 急性心肌梗塞治療
- 急性心肌梗塞的輔助治療
- Sex Difference in the Mortality Trends of Acute Myocardial Infarction in Taiwan, 1974 to 1993
- Cardiac Rupture in Patients with Acute Myocardial Infarction: Report of Three Cases and Review
- Unilateral Renal Hemorrhage Following Thrombolytic Therapy for Acute Myocardial Infarction--A Case Report
- 急性心肌梗塞診斷與處置之新進展
頁籤選單縮合
題 名 | Low Use of Statins in Patients with Acute Myocardial Infarction: A Single Center Experience=急性心肌梗塞患者Statin藥物之使用率偏低:單一醫院之經驗 |
---|---|
作 者 | 殷偉賢; 王鑑忠; 任勗龍; 江孟橙; 黃文彬; 馮安寧; 楊永年; 林昌琦; 楊茂勳; | 書刊名 | Acta Cardiologica Sinica |
卷 期 | 23:2 2007.06[民96.06] |
頁 次 | 頁79-88 |
分類號 | 415.3161 |
關鍵詞 | Statin藥物; 急性心肌梗塞; 臨床預後; Statins; Acute myocardial infarction; Prognosis; |
語 文 | 英文(English) |
中文摘要 | 背景 當前的美國臨床治療指引建議所有急性心肌梗塞患者出院時都應處方Statin藥物,然而國內迄今這方面之資料付諸闕如。本研究之目的即在探討現今國內急性心肌梗塞息者使用Statin藥物之狀況以及使用Statin藥物對臨床預後的影響。 方法及結果 本研究回溯分析了325位(平約年齡62±13歲;男女比258/67)因急性心肌梗塞入院之患者。Statin藥物之使用與否取決於各處方之主治醫師。病人依是否連續使用Statin藥物分為兩組:連續服用Statin藥物者有167位,占51%;未連續服用Statin藥物者有158位,占49%。連續服用Statin藥物之定義為自因急性心肌梗塞入院到追蹤結束止其服用Statin藥物之順從性至少85%者;未服用Statin藥物或斷續服用Statin藥物,其服藥順從性未達85%者,視為未連續服用Statin藥物。分析香現連續使用Statin藥物可顯著降低未來發生不良臨床事件之風險(連續服藥者之不良事件發生率為38%;未連續服藥者為68%;P<0.0001)。多變項分析校正各項可能影響預後之臨床指標後,連續服用Statin藥物者與未連續服藥者之危險比為0.56(95%信賴區間為0.32至0.97,P值為0.039)。 結論 急性心肌梗塞患者連續使用Statin藥物可明顯降低日後發生不良臨床事件之風險,然而目前僅約五成左右的使用率與臨床治療指引所建議者相比仍偏低,表示在實際臨床治療上提升急性心肌梗塞患者Statin藥物的使用,仍有值得努力的空間。 |
英文摘要 | Background: Current guidelines recommend that patients with acute myocardial infarction (AMI) should be discharged on statin therapy. However, little data are available regarding the usage of statin in AMI patients in real-world practice. The present study investigated the current status of statin use and the effect of continuous statin treatment on clinical outcomes in patients with AMI. Methods and Results: Three hundred and twenty-five patients (aged 62±13 years, M/F=258/67) with AMI were enrolled. The administration of statin therapy was at the discretion of the treating physician. Patients were classified into 2 groups: patients receiving continuous statin therapy, defined as at least 85% of statin intake throughout the whole study period (adherent group, n = 167, 51%) and patients not taking continuous statin therapy (nonadherent group, n=158, 49%). Continuous statin therapy was independently associated with a reduction in the risk of adverse clinical outcomes (38% versus 68%; P<0.0001). By Cox proportional hazard analyses, the adjusted odds ratio for the development of adverse events in the adherent group compared with the nonadherent group was 0.56 (95% CI, 0.32 to 0.97, P=0.039). Conclusion: Continuous statin therapy may reduce the risk of adverse clinical outcomes after AMI. However, the relatively low use of statin in the study patients indicates that there remains substantial room to improve implementation of statin therapy to AMI patients in real-world practice. |
本系統中英文摘要資訊取自各篇刊載內容。